Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Accel-KKR to buy Accertify from American Express in strategic tech sector move In a significant move in the technology sector, Accel-KKR, a leading technology-focused private equity firm, has announced the… byPallavi MadhirajuJanuary 16, 2024